173 related articles for article (PubMed ID: 1854172)
1. Comparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.
Chamberland S; Kirst HA; Current WL
Antimicrob Agents Chemother; 1991 May; 35(5):903-9. PubMed ID: 1854172
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
Chang HR; Pechère JC
Antimicrob Agents Chemother; 1988 Apr; 32(4):524-9. PubMed ID: 2837140
[TBL] [Abstract][Full Text] [Related]
3. [In vitro measurement of the inhibitory effect of macrolides, lincosamides and synergestines on the growth of Toxoplasma gondii].
Derouin F; Nalpas J; Chastang C
Pathol Biol (Paris); 1988 Dec; 36(10):1204-10. PubMed ID: 3070460
[TBL] [Abstract][Full Text] [Related]
4. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Araujo FG; Shepard RM; Remington JS
Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Toxoplasma gondii protein synthesis by azithromycin.
Blais J; Garneau V; Chamberland S
Antimicrob Agents Chemother; 1993 Aug; 37(8):1701-3. PubMed ID: 8215287
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo effects of doxycycline on Toxoplasma gondii.
Chang HR; Comte R; Pechère JC
Antimicrob Agents Chemother; 1990 May; 34(5):775-80. PubMed ID: 2360817
[TBL] [Abstract][Full Text] [Related]
7. The ketolide antibiotics HMR 3647 and HMR 3004 are active against Toxoplasma gondii in vitro and in murine models of infection.
Araujo FG; Khan AA; Slifer TL; Bryskier A; Remington JS
Antimicrob Agents Chemother; 1997 Oct; 41(10):2137-40. PubMed ID: 9333038
[TBL] [Abstract][Full Text] [Related]
8. In vitro evaluation of the activities of azithromycin alone and combined with pyrimethamine against Toxoplasma gondii.
Cantin L; Chamberland S
Antimicrob Agents Chemother; 1993 Sep; 37(9):1993-6. PubMed ID: 8239619
[TBL] [Abstract][Full Text] [Related]
9. Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
Franco PS; Gomes AO; Barbosa BF; Angeloni MB; Silva NM; Teixeira-Carvalho A; Martins-Filho OA; Silva DA; Mineo JR; Ferro EA
Placenta; 2011 Nov; 32(11):838-44. PubMed ID: 21908042
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of TNF-alpha and IFN-gamma in retinal cell infection with Toxoplasma gondii.
Delair E; Creuzet C; Dupouy-Camet J; Roisin MP
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1754-60. PubMed ID: 19321794
[TBL] [Abstract][Full Text] [Related]
11. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.
Beckers CJ; Roos DS; Donald RG; Luft BJ; Schwab JC; Cao Y; Joiner KA
J Clin Invest; 1995 Jan; 95(1):367-76. PubMed ID: 7814637
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin.
Pfefferkorn ER; Borotz SE
Antimicrob Agents Chemother; 1994 Jan; 38(1):31-7. PubMed ID: 8141576
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic activity and anti-Toxoplasma effects of artemether on the tachyzoites and experimental infected Vero and J774 cell lines by Toxoplasma gondii.
Mikaeiloo H; Ghaffarifar F; Dalimi A; Sharifi Z; Hassan ZM
Indian J Pharmacol; 2016; 48(2):179-85. PubMed ID: 27127321
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.
Chang HR; Jefford CW; Pechère JC
Antimicrob Agents Chemother; 1989 Oct; 33(10):1748-52. PubMed ID: 2589842
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents.
Zhang HB; Shen QK; Wang H; Jin C; Jin CM; Quan ZS
Eur J Med Chem; 2018 Oct; 158():414-427. PubMed ID: 30237124
[TBL] [Abstract][Full Text] [Related]
17. Effect of clindamycin on intracellular replication, protein synthesis, and infectivity of Toxoplasma gondii.
Blais J; Tardif C; Chamberland S
Antimicrob Agents Chemother; 1993 Dec; 37(12):2571-7. PubMed ID: 7509143
[TBL] [Abstract][Full Text] [Related]
18. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
19. Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
Araujo FG; Huskinson J; Remington JS
Antimicrob Agents Chemother; 1991 Feb; 35(2):293-9. PubMed ID: 2024964
[TBL] [Abstract][Full Text] [Related]
20. [In vitro effect of (+)-usnic acid on Toxoplasma gondii tachyzoites].
Wei LL; Cheng YB; Si KW; Gu N; Li XQ; Li C; Yuan YK
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2008 Dec; 26(6):438-41. PubMed ID: 19288918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
